Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Bloomberg Analysts Now See a 75% Chance A Spot Bitcoin ETF Will Launch In 2023
  2. Cryptos Plunge Amidst Bad News, Bitcoin Drops To $25.4k
  3. $BTC: Morgan Creek Capital CEOStands by His $250K Price Target for Bitcoin
  4. Bitcoin Supply on Exchanges Hits Lowest Level in Over Five Years
  5. Market Trends At This Hour